Flow cytometry susceptibility testing for the antifungal caspofungin

Journal of Clinical Microbiology

Volumn 43, Issue 6, 2005, Pages 2586-2589

  Mitchell, M ^a,b   Hudspeth, M ^b   Wright, A ^b  

^a Fresno Heart Hospital Community Medical Centers of Central California   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDA ZEYLANOIDES; DILUTION; DRUG SENSITIVITY; FLOW CYTOMETRY; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; YARROWIA LIPOLYTICA;

ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; FLOW CYTOMETRY; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; TIME FACTORS;

CANDIDA;

EID: 20444506801     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.6.2586-2589.2005     Document Type: Article

References (13)

1. Bachmann, S. P., T. F. Patterson, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J. Clin. Microbiol. 40:2228-2230.
2. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
3. Chaturvedi, V., R. Ramani, and M. A. Pfaller. 2004. Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans. J. Clin. Microbiol. 42:2249-2251.
4. Chaturvedi, V., and R. Ramani. 2000. Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test. Antimicrob. Agents Chemother. 44:2752-2758.
5. Kirk, S. M., S. M. Callister, L. C. M. Lim, and R. F. Schell. 1997. Rapid susceptibility testing of Candida albicans by flow cytometry. J. Clin. Microbiol. 35:358-363.
6. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Odds, F. C., M. Motyl, R. Andrade, J. Bille, E. Canton, M. Cuenca-Estrella, A. Davidson, C. Durussel, D. Ellis, E. Foraker, A. Fothergill, M. A. Ghannoum, R. A. Giacobbe, M. Gobernado, R. Handke, M. Laverdiere, W. Lee-Yang, W. G. Merz, L. Ostrosky-Zeichner, J. Peman, S. Perea, J. R. Perfect, M. A. Pfaller, L. Proia, J. H. Rex, M. G. Rinaldi, J. Rodriguez-Tudella, W. Schell, C. Shields, D. A. Sutton, P. E. Verweij, and D. W. Warnock. 2004. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42:3475-3482.
8. O'Gorman, M. R. G., and R. L. Hopfer. 1991. Amphotericin B susceptibility testing of Candida species by flow cytometry. Cytometry 12:743-747.
9. Pfaller, M. A., D. J. Diekema, S. A. Messer, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob. Agents Chemother. 47:1068-1071.
10. Pfaller, M. A., S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2003. Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J. Clin. Microbiol. 41:5729-5731.
11. Pfaller, M. A., S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2004. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates. J. Clin. Microbiol. 42:3117-3119.
12. Wenisch, C., K. F. Linnau, B. Parschalk, K. Zedtwitz-Lieberwstein, and A. Georgopoulos. 1997. Rapid susceptibility testing of fungi by flow cytometry using vital staining. J. Clin. Microbiol. 35:5-10.
13. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.